首页> 外文期刊>Analytical chemistry >Statistical Total Correlation Spectroscopy Editing of ~(1)H NMR Spectra of Biofluids: Application to Drug Metabolite Profile Identification and Enhanced Information Recovery
【24h】

Statistical Total Correlation Spectroscopy Editing of ~(1)H NMR Spectra of Biofluids: Application to Drug Metabolite Profile Identification and Enhanced Information Recovery

机译:统计总相关光谱编辑的生物流体的〜(1)H NMR谱:在药物代谢物谱鉴定和增强的信息回收中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Here we present a novel method for enhanced NMR spectral information recovery, utilizing a statistical total correlation spectroscopy editing (STOCSY-E) procedure for the identification of drug metabolite peaks in biofluids and for deconvolution of drug and endogenous metabolite signals. Structurally correlated peaks from drug metabolites and those from closely related drug metabolite pathways are first identified using STOCSY. Subsequently, this correlation information is utilized to scale the biofluid ~(1)H NMR spectra across these identified regions, producing a modified set of spectra in which drug metabolite contributions are reduced and, thus, facilitating analysis by pattern recognition methods without drug metabolite interferences. The application of STOC-SY-E is illustrated with two exemplar ~(1)H NMR spectroscopic data sets, posing various drug metabolic, toxicological, and analytical challenges viz. 800 MHz ~(1)H spectra of human urine (n velence 21) collected over 10 h following dosing with the antibiotic flucloxacillin and 600 MHz ~(1)H NMR spectra of rat urine (n velence 27) collected over 48 h following exposure to the renal papillary toxin 2-bromoethanamine (BEA). STOCSY-E efficiently identified and removed the major xenobiotic metabolite peaks in both data sets, providing enhanced visualization of endogenous changes via orthogonal to projection filtered partial least-squares discriminant analysis (OPLS-DA). OPLS-DA of the STOCSY-E spectral data from the BEA-treated rats revealed the gut bacterial-mammalian co-metabolite phenylacetylglycine as a previously unidentified surrogate biomarker of toxicity. STOCSY-E has a wide range of potential applications in clinical, epidemiology, toxicology, and nutritional studies where multiple xenobiotic metabolic interferences may confound biological interpretation. Additionally, this tool could prove useful for applications outside of metabolic analysis, for example, in process chemistry for following chemical reactions and equilibria and detecting impurities.
机译:在这里,我们介绍了一种用于增强NMR光谱信息恢复的新方法,该方法利用统计总相关光谱编辑(STOCSY-E)程序来识别生物流体中的药物代谢物峰,并对药物和内源性代谢物信号进行去卷积。首先使用STOCSY识别来自药物代谢物和紧密相关药物代谢途径的结构相关峰。随后,该相关信息用于在这些已识别区域上缩放生物流体〜(1)H NMR谱图,从而生成一组经过修改的谱图,其中减少了药物代谢物的贡献,因此,有助于通过模式识别方法进行分析,而无药物代谢物的干扰。 STOC-SY-E的应用通过两个示例的〜(1)H NMR光谱数据集进行了说明,这对各种药物代谢,毒理学和分析挑战提出了挑战。抗生素氟氯西林给药后10小时内收集的人尿(nvelence 21)的800 MHz〜(1)H光谱和暴露后48小时内收集的大鼠尿液(nvelence 27)的600 MHz〜(1)H NMR光谱肾乳头毒素2-溴乙胺(BEA)。 STOCSY-E有效地识别并去除了两个数据集中的主要异源代谢物峰,通过正交于投影滤波的偏最小二乘判别分析(OPLS-DA),提供了内生变化的增强可视化。来自经BEA的大鼠的STOCSY-E光谱数据的OPLS-DA显示,肠道细菌-哺乳动物共代谢物苯基乙酰基甘氨酸是以前未确定的毒性替代生物标志物。 STOCSY-E在临床,流行病学,毒理学和营养学研究中具有广泛的潜在应用,在这些研究中,多种异源生物代谢干扰可能会混淆生物学解释。此外,该工具还可用于代谢分析以外的应用,例如,在过程化学中跟踪化学反应和平衡以及检测杂质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号